VIA
ABBV icon

Vantis Investment Advisers’s AbbVie ABBV Stock Holding History

Vantis Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,450,000
Closed -$137M – 18
2018
Q1 		$137M Hold
1,450,000
– – 39.74% 1
2017
Q4 		$140M Hold
1,450,000
– – 68.85% 1
2017
Q3 		$129M Buy
1,450,000
+1,302,866
+885% +$99.2M 68.13% 1
2017
Q2 		$10.7M Hold
147,134
– – 15.34% 4
2017
Q1 		$9.59M Buy
+147,134
New +$9.25M 4.57% 8

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vantis Investment Advisers's ABBV Position: Q2 2018 in Review

Vantis Investment Advisers sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 1,450,000 shares — an estimated $137M sold.

Vantis Investment Advisers first reported a position in ABBV in Q1 2017 and held it in 5 quarters. The position peaked at $140M in Q4 2017. 1,997 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Vantis Investment Advisers reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • Vantis Investment Advisers sold 1,450,000 AbbVie shares in Q2 2018, an estimated $137M.
  • Vantis Investment Advisers first reported a position in AbbVie in Q1 2017 and held it in 5 quarters.
  • Vantis Investment Advisers's AbbVie position peaked at $140M in Q4 2017.
  • 1,997 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Vantis Investment Advisers's 13F filing for Q2 2018, filed 13 Aug 2018.